Search for: "Elan Pharmaceuticals Inc"
Results 41 - 55
of 55
Sorted by Relevance
|
Sort by Date
25 Apr 2007, 11:26 pm
Elan Pharms., Inc. v. [read post]
19 May 2011, 9:12 pm
Elan Pharmaceutical Research Corp., we considered an analogous situation in a different procedural posture. 212 F.3d at 1247-50... [read post]
30 Apr 2012, 7:54 pm
Trade Comm’n, 402 F.3d 1056 (11th Cir. 2005), and Andrx Pharmaceuticals, Inc. v. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
28 Sep 2015, 9:07 am
Teva Pharmaceuticals USA, Inc., 549 Fed. [read post]
11 Apr 2011, 7:15 pm
Elan Pharmaceuticals, 616 F.3d 1267, 1274 (Fed. [read post]
26 Mar 2014, 7:38 pm
Takeda Pharmaceuticals, Inc. [read post]
28 Nov 2006, 4:11 pm
Elan Pharms., Inc. v. [read post]
17 Apr 2009, 5:00 am
(IAM) US Federal Trade Commission considers issues in patent damages awards (IP Law Blog) Lockheed case reveals legislative gap in patent law (Law 360) Pepsi strikes back at Coke over sports drink ads (Law 360) Automotive Technologies International Inc. drops one of its four patent infringement claims against GM, Ford and others (Law 360) Judge halts jury trial to hand ADT Security Services Inc. win in an infringement suit brought by Paradox Security Systems Ltd over telephone… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
3 Apr 2014, 2:49 pm
The petitioners in the patent-infringement case Teva Pharmaceuticals USA, Inc. v. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
19 Jul 2022, 2:59 pm
BioMimetic Therapeutics, Inc., 2013 WL 139521, at *13-14 (M.D. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
